COLLEGIUM PHARMACEUTICAL, INC - COM (COLL)

Historical Portfolio Holders from Q2 2015 to Q1 2024

All holders as of March 31, 2024: Q1 2024
Type / Class: Equity / COM
Shares, excl. options Q1 2024: 14.7 M
Holdings value Q1 2024: $571 M
Value change Q1 2024: +$16.6 M
Grand Portfolio weight change Q1 2024: +0%
Number of holders: 94
Number of buys Q1 2024: 53
Number of sells Q1 2024: -49
Average buys Q1 2024 %: +0.001%
Average sells Q1 2024 %: 0%
CUSIP: 19459J104

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Period	Shares, Excl. Options	Value, Excl. Options	Change	Puts Notional Value	Calls Notional Value	Price	Investors
2024 Q1	14.7 M	$571 M	+$16.6 M	598 K	1.58 M	$38.82	94
2023 Q4	37.7 M	$1.16 B	+$2.8 M	1.45 M	212 K	$30.78	187
2023 Q3	38.6 M	$864 M	-$13.2 M	932 K	0	$22.35	173
2023 Q2	39.1 M	$840 M	+$2.46 M	948 K	122 K	$21.49	176
2023 Q1	38.9 M	$933 M	+$74.1 M	281 K	173 K	$23.99	195
2022 Q4	35.8 M	$831 M	+$6.7 M	32.5 K	1.51 M	$23.20	169
2022 Q3	35.3 M	$566 M	-$20 M	0	888 K	$16.02	151
2022 Q2	36 M	$638 M	+$14.3 M	197 K	628 K	$17.72	149
2022 Q1	35.8 M	$728 M	+$7.11 M	497 K	719 K	$20.36	157
2021 Q4	35.5 M	$664 M	-$14.4 M		0	$18.68	147
2021 Q3	36.4 M	$718 M	-$39 M		310 K	$19.74	149
2021 Q2	37.9 M	$897 M	-$28.8 K	0	0	$23.64	153
2021 Q1	38 M	$901 M	+$56.4 M	1.08 M	2.14 M	$23.70	161
2020 Q4	35.8 M	$717 M	-$716 K	1.63 M	1.85 M	$20.03	130
2020 Q3	37.3 M	$776 M	+$4.08 M	537 K	1.63 M	$20.82	134
2020 Q2	37 M	$647 M	+$3.8 M	469 K	417 K	$17.50	146
2020 Q1	36.8 M	$602 M	+$85.1 M	1.01 M	1.42 M	$16.33	153
2019 Q4	31.5 M	$648 M	+$50.5 M	237 K	1.21 M	$20.58	133
2019 Q3	30 M	$345 M	-$4.71 M	248 K	191 K	$11.48	115
2019 Q2	30.3 M	$398 M	-$8.93 M	421 K	1.12 M	$13.15	124
2019 Q1	30.8 M	$466 M	-$36.7 M	197 K	389 K	$15.14	135
2018 Q4	33 M	$567 M	+$7.94 M	319 K	965 K	$17.17	114
2018 Q3	30.4 M	$448 M	+$12 M	889 K	4.41 M	$14.74	116
2018 Q2	29.1 M	$693 M	+$15.8 M	2.46 M	1.27 M	$23.85	125
2018 Q1	30.2 M	$773 M	+$49.3 M	2 M	1.29 M	$25.55	132
2017 Q4	28.5 M	$526 M	+$70.8 M	1.22 M	358 K	$18.46	98
2017 Q3	26 M	$273 M	+$14.2 M	506 K	0	$10.49	73
2017 Q2	24.5 M	$307 M	+$19.6 M	478 K	149 K	$12.51	68
2017 Q1	23.3 M	$235 M	+$9.38 M	252 K	515 K	$10.06	79
2016 Q4	23.3 M	$363 M	+$116 M	701 K	229 K	$15.57	84
2016 Q3	15.9 M	$306 M	+$29.4 M	867 K		$19.26	70
2016 Q2	14.6 M	$173 M	-$10.8 M			$11.85	72
2016 Q1	14.9 M	$269 M	+$53.1 M			$18.15	68
2015 Q4	11.9 M	$327 M	+$13.5 M			$27.50	57
2015 Q3	8.69 M	$192 M	+$23 M			$22.11	44
2015 Q2	9.28 M	$165 M	+$138 M			$17.84	45